Retroclavicular Block in Vascular Surgey
ConditionPain Management
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-65
SponsorNew Valley University
About this trial
The retroclavicular (coracoid) approach for brachial plexus anesthesia is recognized for its facility and simplicity to perform .
The block has been well described in the anesthesia community since it was first introduced by Hebbard and Royse in 2007 . In 2017, Luftig . first described the block's use in the ED setting for a variety of indications . Because of its different needle entry point, the retro clavicular (RCB) approach offers an almost perpendicular needle-ultrasound (US) beam angle.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing upper limb vascular surgey .
Disqualifiers
- Contraindications to regional block (coagulopathy, infection at the needle insertion site, or diaphragmatic paralysis).
Altered conscious level.
Pregnancy.
Body mass index (BMI > 35).
Trial design
Design model
Parallel
Treatments tested in this trial
retroclavicular block
Other interventionregional anesthesia
Treatment groups
80 Participants
are divided into 2 treatment groupsGroup A: dexamethasone with bupivacaine in retroclavicular blockActive comparator 1 intervention
Group B: bupivacaine in retroclavicular block (control group)Active comparator 1 intervention
Trial outcomes
Primary outcomes
1
sensory and motor duration of block
efficacy of block
Time frame
24 hoursSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov